<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="article-commentary" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Aging Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Aging Dis</journal-id>
<journal-title-group>
<journal-title>Aging and Disease</journal-title>
</journal-title-group>
<issn pub-type="epub">2152-5250</issn>
<publisher>
<publisher-name>JKL International LLC</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32765939</article-id>
<article-id pub-id-type="pmc">7390525</article-id>
<article-id pub-id-type="publisher-id">ad-11-4-737</article-id>
<article-id pub-id-type="doi">10.14336/AD.2020.0518</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Commentary</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>COVID-19 and Senotherapeutics: Any Role for the Naturally-occurring Dipeptide Carnosine?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hipkiss</surname>
<given-names>Alan R</given-names>
</name>
<aff>Aston Research Centre for Healthy Ageing (ARCHA), Aston University, Birmingham, B4 7ET, UK</aff>
<xref ref-type="corresp" rid="cor1-ad-11-4-737">
<sup>*</sup>
</xref>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1-ad-11-4-737"><label>*</label>Correspondence should be addressed to: Dr. Alan R. Hipkiss, Aston Research Centre for Healthy Ageing (ARCHA), Aston University, Birmingham, B4 7ET, UK. Email: <email>alanandjill@lineone.net</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<month>7</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>7</month>
<year>2020</year>
</pub-date>
<volume>11</volume>
<issue>4</issue>
<fpage>737</fpage>
<lpage>741</lpage>
<history>
<date date-type="received">
<day>15</day>
<month>5</month>
<year>2020</year>
</date>
<date date-type="rev-request">
<day>17</day>
<month>5</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>5</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © 2020 Hipkiss et al.</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.</license-p>
</license>
</permissions>
<abstract>
<p>It is suggested that the non-toxic dipeptide carnosine (beta-alanyl-L-histidine) should be examined as a potential protective agent against COVID-19 infection and inflammatory consequences especially in the elderly. Carnosine is an effective anti-inflammatory agent which can also inhibit CD26 and ACE2 activity. It is also suggested that nasal administration would direct the peptide directly to the lungs and escape the attention of serum carnosinase.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>carnosine</kwd>
<kwd>acetyl-carnosine</kwd>
<kwd>inflammation</kwd>
<kwd>virus</kwd>
<kwd>olfaction</kwd>
<kwd>lungs</kwd>
<kwd>aging</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>It has become clear that, compared to the young, elderly humans are especially susceptible to fatal infection by COVID-19, most likely due, it is thought, to pre-existing, age-related, underlying conditions. Consequently, a number of recent publications [1,2,3.4] have discussed how the processes of ageing might enhance the impact of the COVID-19 virus upon human physiology. Furthermore, it has been proposed that agents which suppress ageing onset and/or development, should be explored for mitigation of COVID-19 toxicity and mortality in the elderly [<xref ref-type="bibr" rid="b1-ad-11-4-737">1</xref>,<xref ref-type="bibr" rid="b3-ad-11-4-737">3</xref>,<xref ref-type="bibr" rid="b4-ad-11-4-737">4</xref>]. Indeed, a search for effective senotherapeutics has considered a range of possible anti-aging agents and the mechanistic routes that might ameliorate age-related change [<xref ref-type="bibr" rid="b3-ad-11-4-737">3</xref>]. It is proposed here that the naturally-occurring dipeptide carnosine (beta-alanyl-L-histidine) should also be considered as a potential senotherapeutic which may help to suppress COVID-19 toxicity.</p>
<sec>
<title>Carnosine, aging and COVID-19</title>
<p>There is evidence, first obtained more than 25 years ago, that carnosine delays senescence, extends lifespan and even rejuvenates cultured human lung fibroblasts [<xref ref-type="bibr" rid="b5-ad-11-4-737">5</xref>]. Subsequent studies revealed that carnosine (i) can delay ageing and/or related phenomena in some animal models [<xref ref-type="bibr" rid="b6-ad-11-4-737">6</xref>-<xref ref-type="bibr" rid="b10-ad-11-4-737">10</xref>], (ii) possesses anti-oxidant and anti-glycating activities [<xref ref-type="bibr" rid="b11-ad-11-4-737">11</xref>-<xref ref-type="bibr" rid="b15-ad-11-4-737">15</xref>], (iii) possesses anti-inflammatory properties [<xref ref-type="bibr" rid="b16-ad-11-4-737">16</xref>-<xref ref-type="bibr" rid="b20-ad-11-4-737">20</xref>], (iv) is protective towards lung injury [<xref ref-type="bibr" rid="b21-ad-11-4-737">21</xref>-<xref ref-type="bibr" rid="b23-ad-11-4-737">23</xref>], (v) can decrease the infectivity of RNA viruses Zika, Denge [<xref ref-type="bibr" rid="b24-ad-11-4-737">24</xref>] and influenza [<xref ref-type="bibr" rid="b25-ad-11-4-737">25</xref>], (vi) is an inhibitor of CD26 (also known and dipeptidyl peptidase IV (DPP4) [<xref ref-type="bibr" rid="b26-ad-11-4-737">26</xref>,<xref ref-type="bibr" rid="b27-ad-11-4-737">27</xref>] and ACE-2 (angiotensin converting enzyme 2) [<xref ref-type="bibr" rid="b28-ad-11-4-737">28</xref>,<xref ref-type="bibr" rid="b29-ad-11-4-737">29</xref>], i.e. the cell receptors to which COVID-19 attaches to ensure infection [<xref ref-type="bibr" rid="b30-ad-11-4-737">30</xref>,<xref ref-type="bibr" rid="b31-ad-11-4-737">31</xref>], (vii) can complex with zinc ions to form polaprezinc [<xref ref-type="bibr" rid="b32-ad-11-4-737">32</xref>]; it has been reported that zinc ions can inhibit COVID-19 RNA polymerase thus suppressing viral replication [<xref ref-type="bibr" rid="b33-ad-11-4-737">33</xref>].</p>
</sec>
<sec>
<title>Carnosine and blood</title>
<p>Another role for carnosine could include beneficial effects in blood. Recent findings suggest that COVID-19 infection can promote in some patients a hyper-coagulatory state, which is associated increased mortality [<xref ref-type="bibr" rid="b34-ad-11-4-737">34</xref>]. The glycolytic by-product methylglyoxal (MG) is generated in increased amounts in type-2 diabetics, especially in erythrocytes following high glycemic-index diets [<xref ref-type="bibr" rid="b35-ad-11-4-737">35</xref>]. MG is responsible for much post-synthetic protein glycation in diabetics, including the anti-coagulants anti-thrombin III [<xref ref-type="bibr" rid="b36-ad-11-4-737">36</xref>] and plasminogen [<xref ref-type="bibr" rid="b37-ad-11-4-737">37</xref>], resulting in a hyper-coagulatory state. Given that carnosine can inhibit protein glycation and possibly scavenge MG, the dipeptide might suppress the MG-induced anti-coagulant modification.</p>
<p>Recent studies have shown that carnosine and acetyl-carnosine are present in human blood; carnosine is present in erythrocytes and acetyl-carnosine is mostly in serum; erythrocytes normally contain carnosine and 10-fold less acetyl-carnosine, while the situation is reversed in serum where acetyl-carnosine is the predominant form. Importantly, these levels decline in elderly humans [<xref ref-type="bibr" rid="b38-ad-11-4-737">38</xref>] and low levels of acetyl-carnosine are associated with enhanced frailty [<xref ref-type="bibr" rid="b39-ad-11-4-737">39</xref>]. Low carnosine levels have also been detected in blood from patients suffering from age-related macular degeneration [<xref ref-type="bibr" rid="b40-ad-11-4-737">40</xref>].</p>
<p>It is perhaps interesting to note that carnosine synthesis may be affected by trauma, even in the distant past, which could influence an individual’s blood carnosine and acetyl-carnosine levels. In adults subjected to childhood trauma, the carnosine synthase gene showed increased methylation, which would decrease carnosine synthesis [<xref ref-type="bibr" rid="b41-ad-11-4-737">41</xref>]. Childhood trauma has been linked to psychopathology, accelerated aging-related DNA methylation [<xref ref-type="bibr" rid="b42-ad-11-4-737">42</xref>] and schizophrenia [<xref ref-type="bibr" rid="b43-ad-11-4-737">43</xref>]. Furthermore, erythrocytes from schizophrenics show evidence of increased aging-related protein glycation [<xref ref-type="bibr" rid="b44-ad-11-4-737">44</xref>], while dietary carnosine supplementation has been shown to produce beneficial effects in schizophrenics [<xref ref-type="bibr" rid="b45-ad-11-4-737">45</xref>], possibly due, in part, to carnosine’s anti-glycating activity [<xref ref-type="bibr" rid="b11-ad-11-4-737">11</xref>,<xref ref-type="bibr" rid="b12-ad-11-4-737">12</xref>].</p>
</sec>
<sec>
<title>Carnosine as a possible senotherapeutic</title>
<p>All the factors outlined above, lead one to suggest that carnosine should be considered as a possible senotherapeutic, acting either prophylactically by helping to suppress the development of an increasingly frail senescent phenotype and/or therapeutically by interfering with COVID-19 infection (given its reported effects on DPP4 and ACE2). Furthermore, carnosine’s anti-inflammatory effects may help suppress post-infection inflammatory response and fibrosis [<xref ref-type="bibr" rid="b46-ad-11-4-737">46</xref>]. It may also be significant that loss of a sense of smell frequently accompanies COVID-19 infection [<xref ref-type="bibr" rid="b47-ad-11-4-737">47</xref>], and that the olfactory lobe is normally enriched with carnosine [<xref ref-type="bibr" rid="b48-ad-11-4-737">48</xref>]. Consequently, it is suggested that the dipeptide is worth exploring for suppression of COVID-19 toxicity in aged humans, especially in subjects already possessing age-related dysfunction.</p>
<p>As noted above, a decreased serum level of acetyl-carnosine (unsusceptible to hydrolysis by serum carnosinase) has recently been noted as an indicator of frailty in elderly humans [<xref ref-type="bibr" rid="b39-ad-11-4-737">39</xref>], thus it may be informative if blood levels of acetyl-carnosine and carnosine could be determined in COVID-19 infected patients.</p>
<p>There have been a number of studies in which dietary supplementation with carnosine has been explored. Beneficial effects have been observed in schizophrenics [<xref ref-type="bibr" rid="b45-ad-11-4-737">45</xref>], Gulf War veterans [<xref ref-type="bibr" rid="b49-ad-11-4-737">49</xref>], obese humans [<xref ref-type="bibr" rid="b50-ad-11-4-737">50</xref>], diabetics [<xref ref-type="bibr" rid="b51-ad-11-4-737">51</xref>], elderly human verbal memory [<xref ref-type="bibr" rid="b52-ad-11-4-737">52</xref>], autistic children [<xref ref-type="bibr" rid="b53-ad-11-4-737">53</xref>,<xref ref-type="bibr" rid="b54-ad-11-4-737">54</xref>] and patients with chronic heart failure [<xref ref-type="bibr" rid="b55-ad-11-4-737">55</xref>]. Unfortunately, a major problem with oral administration of carnosine is the presence of carnosinase in serum which will destroy the peptide; indeed high carnosinase activity can limit the efficacy of orally administered carnosine towards chronic kidney disease [<xref ref-type="bibr" rid="b56-ad-11-4-737">56</xref>]. An alternative approach would be to use nasal delivery, either as an aerosol or in powder form, thus eliminating the serum carnosinase problem and targeting carnosine directly to the lungs. Hopefully this would suppress COVID-19 infectivity via the dipeptide’s inhibitory effects on both ACE2 and MPP4. Moreover, carnosine’s well-recognised anti-inflammatory activity could suppress any excessive inflammatory response following infection. Such an approach may be especially important in frail subjects, exhibiting low levels of acetyl-carnosine (resistant to carnosinase attack). The precise relationship between these two molecules remains to be revealed; for example, is red cell carnosine a precursor of acetyl-carnosine which is then released from the cell?</p>
</sec>
<sec>
<title>Conclusion.</title>
<p>Carnosine has previously been described as enigmatic [<xref ref-type="bibr" rid="b57-ad-11-4-737">57</xref>], and the dipeptide has been shown to exert a variety of effects at biochemical and physiological levels resulting in a large number of possible biological functions [<xref ref-type="bibr" rid="b58-ad-11-4-737">58</xref>]. Indeed, as aging is multifactorial, any putative anti-aging agent might be expected to be pluripotent in its actions [<xref ref-type="bibr" rid="b59-ad-11-4-737">59</xref>]. Thus, carnosine’s cumulative multifunctional activities could result in a physiologically beneficial outcome in COVID-19 infected aged humans. In order to decrease virus-associated mortality, it is suggested that elderly subjects with low blood carnosine and acetyl-carnosine levels should receive exogenous carnosine, administered nasally.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="COI-statement">
<p>
<bold>Conflict of interest</bold>
</p>
<p>The author has no conflict of interest.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="b1-ad-11-4-737">
<label>[1]</label>
<mixed-citation publication-type="journal"><name><surname>Malavolta</surname><given-names>M</given-names></name>, <name><surname>Giacconi</surname><given-names>R</given-names></name>, <name><surname>Brunetti</surname><given-names>D</given-names></name>, <name><surname>Provinciali</surname><given-names>M</given-names></name>, <name><surname>Maggi</surname><given-names>F</given-names></name> (<year>2020</year>). <article-title>Exploring the Relevance of Senotherapeutics for the Current SARS-CoV-2. Emergency and Similar Future Global Health Threats</article-title>. <source/>Cells, <volume>9</volume>(<issue>4</issue>):<fpage>E909</fpage>.<pub-id pub-id-type="pmid">32276453</pub-id></mixed-citation>
</ref>
<ref id="b2-ad-11-4-737">
<label>[2]</label>
<mixed-citation publication-type="journal"><name><surname>Lauc</surname><given-names>G</given-names></name>, <name><surname>Sinclair</surname><given-names>D</given-names></name> (<year>2020</year>). <article-title>Biomarkers of biological age as predictors of COVID-19 disease severity</article-title>. <source/>Aging, in press.</mixed-citation>
</ref>
<ref id="b3-ad-11-4-737">
<label>[3]</label>
<mixed-citation publication-type="journal"><name><surname>Zhavoronkov</surname><given-names>A</given-names></name> (<year>2020</year>). <article-title>Geroprotective and Senoremediative Strategies to Reduce the Comorbidity, Infection Rates, Severity, and Lethality in Gerophilic and Gerolavic Infections</article-title>. <source/>Aging, <volume>12</volume>:<fpage>6492</fpage>-<lpage>6510</lpage>.<pub-id pub-id-type="pmid">32229705</pub-id></mixed-citation>
</ref>
<ref id="b4-ad-11-4-737">
<label>[4]</label>
<mixed-citation publication-type="journal"><name><surname>Promislow</surname><given-names>DEL</given-names></name> (<year>2020</year>). <article-title>A geroscience perspective on COVID-19 mortality</article-title>. <source/>J Gerontol A Biol Sci Med Sci, in press.</mixed-citation>
</ref>
<ref id="b5-ad-11-4-737">
<label>[5]</label>
<mixed-citation publication-type="journal"><name><surname>McFarland</surname><given-names>GA</given-names></name>, <name><surname>Holliday</surname><given-names>R</given-names></name> (<year>1994</year>). <article-title>Retardation of the senescence of cultured human diploid fibroblasts by carnosine</article-title>. <source/>Exp Cell Res, <volume>212</volume>(<issue>2</issue>):<fpage>167</fpage>-<lpage>75</lpage>.<pub-id pub-id-type="pmid">8187813</pub-id></mixed-citation>
</ref>
<ref id="b6-ad-11-4-737">
<label>[6]</label>
<mixed-citation publication-type="journal"><name><surname>Stvolinsky</surname><given-names>S</given-names></name>, <name><surname>Antipin</surname><given-names>M</given-names></name>, <name><surname>Meguro</surname><given-names>K</given-names></name>, <name><surname>Sato</surname><given-names>T</given-names></name>, <name><surname>Abe</surname><given-names>H</given-names></name>, <name><surname>Boldyrev</surname><given-names>AA</given-names></name> (<year>2010</year>). <article-title>Effect of carnosine and its Trolox-modified derivatives on life span of Drosophila melanogaster</article-title>. <source/>Rejuvenation Res, <volume>13</volume>(<issue>4</issue>):<fpage>453</fpage>-<lpage>7</lpage>.<pub-id pub-id-type="pmid">20681748</pub-id></mixed-citation>
</ref>
<ref id="b7-ad-11-4-737">
<label>[7]</label>
<mixed-citation publication-type="journal"><name><surname>Yuneva</surname><given-names>AO</given-names></name>, <name><surname>Kramarenko</surname><given-names>GG</given-names></name>, <name><surname>Vetreshchak</surname><given-names>TV</given-names></name>, <name><surname>Gallant</surname><given-names>S</given-names></name>, <name><surname>Boldyrev</surname><given-names>AA</given-names></name> (<year>2002</year>). <article-title>Effect of carnosine on Drosophila melanogaster lifespan</article-title>. <source/>Bull Exp Biol Med, <volume>133</volume>(<issue>6</issue>):<fpage>559</fpage>-<lpage>61</lpage><pub-id pub-id-type="pmid">12447464</pub-id></mixed-citation>
</ref>
<ref id="b8-ad-11-4-737">
<label>[8]</label>
<mixed-citation publication-type="journal"><name><surname>Larroque-Cardoso</surname><given-names>P</given-names></name>, <name><surname>Camaré</surname><given-names>C</given-names></name>, <name><surname>Nadal-Wollbold</surname><given-names>F</given-names></name>, <name><surname>Grazide</surname><given-names>MH</given-names></name>, <name><surname>Pucelle</surname><given-names>M</given-names></name>, <name><surname>Garoby-Salom</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2015</year>). <article-title>Elastin Modification by 4-Hydroxynonenal in Hairless Mice Exposed to UV-A. Role in Photoaging and Actinic Elastosis</article-title>. <source/>J Invest Dermatol, <volume>135</volume>(<issue>7</issue>):<fpage>1873</fpage>-<lpage>1881</lpage>.<pub-id pub-id-type="pmid">25739050</pub-id></mixed-citation>
</ref>
<ref id="b9-ad-11-4-737">
<label>[9]</label>
<mixed-citation publication-type="journal"><name><surname>Corona</surname><given-names>C</given-names></name>, <name><surname>Frazzini</surname><given-names>V</given-names></name>, <name><surname>Silvestri</surname><given-names>E</given-names></name>, <name><surname>Lattanzio</surname><given-names>R</given-names></name>, <name><surname>La Sorda</surname><given-names>R</given-names></name>, <name><surname>Piantelli</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2011</year>). <article-title>Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice</article-title>. <source/>PLoS One, <volume>6</volume>(<issue>3</issue>):<fpage>e17971</fpage>.<pub-id pub-id-type="pmid">21423579</pub-id></mixed-citation>
</ref>
<ref id="b10-ad-11-4-737">
<label>[10]</label>
<mixed-citation publication-type="journal"><name><surname>Gallant</surname><given-names>S</given-names></name>, <name><surname>Semyonova</surname><given-names>M</given-names></name>, <name><surname>Yuneva</surname><given-names>M</given-names></name> (<year>2000</year>). <article-title>Carnosine as a potential anti-senescence drug</article-title>. <source/>Biochemistry, <volume>65</volume>(<issue>7</issue>):<fpage>866</fpage>-<lpage>8</lpage>.<pub-id pub-id-type="pmid">10951107</pub-id></mixed-citation>
</ref>
<ref id="b11-ad-11-4-737">
<label>[11]</label>
<mixed-citation publication-type="journal"><name><surname>Aydın</surname><given-names>AF</given-names></name>, <name><surname>Bingül</surname><given-names>İ</given-names></name>, <name><surname>Küçükgergin</surname><given-names>C</given-names></name>, <name><surname>Doğan-Ekici</surname><given-names>I</given-names></name>, <name><surname>Doğru Abbasoğlu</surname><given-names>S</given-names></name>, <name><surname>Uysal</surname><given-names>M</given-names></name> (<year>2017</year>). <article-title>Carnosine decreased oxidation and glycation products in serum and liver of high-fat diet and low-dose streptozotocin-induced diabetic rats</article-title>. <source/>Int J Exp Pathol, <volume>98</volume>(<issue>5</issue>):<fpage>278</fpage>-<lpage>288</lpage>.<pub-id pub-id-type="pmid">29205589</pub-id></mixed-citation>
</ref>
<ref id="b12-ad-11-4-737">
<label>[12]</label>
<mixed-citation publication-type="journal"><name><surname>Bingül</surname><given-names>İ</given-names></name>, <name><surname>Yılmaz</surname><given-names>Z</given-names></name>, <name><surname>Aydın</surname><given-names>AF</given-names></name>, <name><surname>Çoban</surname><given-names>J</given-names></name>, <name><surname>Doğru-Abbasoğlu</surname><given-names>S</given-names></name>, <name><surname>Uysal</surname><given-names>M</given-names></name> (<year>2017</year>). <article-title>Antiglycation and anti-oxidant efficiency of carnosine in the plasma and liver of aged rats</article-title>. <source/>Geriatr Gerontol Int, <volume>17</volume>(<issue>12</issue>):<fpage>2610</fpage>-<lpage>2614</lpage>.<pub-id pub-id-type="pmid">28776910</pub-id></mixed-citation>
</ref>
<ref id="b13-ad-11-4-737">
<label>[13]</label>
<mixed-citation publication-type="journal"><name><surname>Xie</surname><given-names>Z</given-names></name>, <name><surname>Baba</surname><given-names>SP</given-names></name>, <name><surname>Sweeney</surname><given-names>BR</given-names></name>, <name><surname>Barski</surname><given-names>OA</given-names></name> (<year>2013</year>). <article-title>Detoxification of aldehydes by histidine-containing dipeptides: from chemistry to clinical implications</article-title>. <source/>Chem Biol Interact, <volume>202</volume>(<issue>1-3</issue>):<fpage>288</fpage>-<lpage>97</lpage><pub-id pub-id-type="pmid">23313711</pub-id></mixed-citation>
</ref>
<ref id="b14-ad-11-4-737">
<label>[14]</label>
<mixed-citation publication-type="journal"><name><surname>Seidler</surname><given-names>NW</given-names></name>, <name><surname>Yeargans</surname><given-names>GS</given-names></name> (<year>2002</year>). <article-title>Effects of thermal denaturation on protein glycation</article-title>. <source/>Life Sci, <volume>70</volume>(<issue>15</issue>):<fpage>1789</fpage>-<lpage>99</lpage><pub-id pub-id-type="pmid">12002523</pub-id></mixed-citation>
</ref>
<ref id="b15-ad-11-4-737">
<label>[15]</label>
<mixed-citation publication-type="journal"><name><surname>Hipkiss</surname><given-names>AR</given-names></name>, <name><surname>Brownson</surname><given-names>C</given-names></name> (<year>2000</year>). <article-title>Carnosine reacts with protein carbonyl groups: another possible role for the anti-ageing peptide?</article-title>
<source/>Biogerontology, <volume>1</volume>(<issue>3</issue>):<fpage>217</fpage>-<lpage>23</lpage>.<pub-id pub-id-type="pmid">11707898</pub-id></mixed-citation>
</ref>
<ref id="b16-ad-11-4-737">
<label>[16]</label>
<mixed-citation publication-type="journal"><name><surname>Qu</surname><given-names>F</given-names></name>, <name><surname>Xu</surname><given-names>W</given-names></name>, <name><surname>Deng</surname><given-names>Z</given-names></name>, <name><surname>Xie</surname><given-names>Y</given-names></name>, <name><surname>Tang</surname><given-names>J</given-names></name>, <name><surname>Chen</surname><given-names>Z</given-names></name>, <etal>et al</etal> (<year>2020</year>). <article-title>Fish c-Jun N-Terminal Kinase (JNK) Pathway Is Involved in Bacterial MDP-Induced Intestinal Inflammation</article-title>. <source/>Front Immunol, <volume>11</volume>:<fpage>459</fpage>.<pub-id pub-id-type="pmid">32292404</pub-id></mixed-citation>
</ref>
<ref id="b17-ad-11-4-737">
<label>[17]</label>
<mixed-citation publication-type="journal"><name><surname>Impellizzeri</surname><given-names>D</given-names></name>, <name><surname>Siracusa</surname><given-names>R</given-names></name>, <name><surname>Cordaro</surname><given-names>M</given-names></name>, <name><surname>Peritore</surname><given-names>AF</given-names></name>, <name><surname>Gugliandolo</surname><given-names>E</given-names></name>, <name><surname>D'amico</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2020</year>). <article-title>Protective effect of a new hyaluronic acid -carnosine conjugate on the modulation of the inflammatory response in mice subjected to collagen-induced arthritis</article-title>. <source/>Biomed Pharmacother, <volume>125</volume>:<fpage>110023</fpage>.<pub-id pub-id-type="pmid">32092830</pub-id></mixed-citation>
</ref>
<ref id="b18-ad-11-4-737">
<label>[18]</label>
<mixed-citation publication-type="journal"><name><surname>Fresta</surname><given-names>CG</given-names></name>, <name><surname>Fidilio</surname><given-names>A</given-names></name>, <name><surname>Lazzarino</surname><given-names>G</given-names></name>, <name><surname>Musso</surname><given-names>N</given-names></name>, <name><surname>Grasso</surname><given-names>M</given-names></name>, <name><surname>Merlo</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2020</year>). <article-title>Modulation of Pro-Oxidant and Pro-Inflammatory Activities of M1 Macrophages by the Natural Dipeptide Carnosine</article-title>. <source/>Int J Mol Sci, <volume>21</volume>(<issue>3</issue>):<fpage>776</fpage>.</mixed-citation>
</ref>
<ref id="b19-ad-11-4-737">
<label>[19]</label>
<mixed-citation publication-type="journal"><name><surname>Fadda</surname><given-names>LM</given-names></name>, <name><surname>Ali</surname><given-names>HM</given-names></name>, <name><surname>Mohamed</surname><given-names>AM</given-names></name>, <name><surname>Hagar</surname><given-names>H</given-names></name> (<year>2019</year>). <article-title>Prophylactic administration of carnosine and melatonin abates the incidence of apoptosis, inflammation, and DNA damage induced by titanium dioxide nanoparticles in rat livers</article-title>. <source/>Environ Sci Pollut Res Int, in press.</mixed-citation>
</ref>
<ref id="b20-ad-11-4-737">
<label>[20]</label>
<mixed-citation publication-type="journal"><name><surname>Caruso</surname><given-names>G</given-names></name>, <name><surname>Fresta</surname><given-names>CG</given-names></name>, <name><surname>Musso</surname><given-names>N</given-names></name>, <name><surname>Giambirtone</surname><given-names>M</given-names></name>, <name><surname>Grasso</surname><given-names>M</given-names></name>, <name><surname>Spampinato</surname><given-names>SF</given-names></name>, <etal>et al</etal> (<year>2019</year>). <article-title>Carnosine Prevents Aβ-Induced Oxidative Stress and Inflammation in Microglial Cells: A Key Role of TGF-β1</article-title>. <source/>Cells, <volume>8</volume>:<fpage>64</fpage>.</mixed-citation>
</ref>
<ref id="b21-ad-11-4-737">
<label>[21]</label>
<mixed-citation publication-type="journal"><name><surname>Tanaka</surname><given-names>KI</given-names></name>, <name><surname>Kawahara</surname><given-names>M</given-names></name> (<year>2019</year>). <article-title>Carnosine and Lung Disease</article-title>. <source/>Curr Med Chem, in press.</mixed-citation>
</ref>
<ref id="b22-ad-11-4-737">
<label>[22]</label>
<mixed-citation publication-type="journal"><name><surname>Sun</surname><given-names>C</given-names></name>, <name><surname>Wu</surname><given-names>Q</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>He</surname><given-names>Q</given-names></name>, <name><surname>Zhao</surname><given-names>H</given-names></name> (<year>2017</year>). <article-title>Mechanistic Evaluation of the Protective Effect of Carnosine on Acute Lung Injury in Sepsis Rats</article-title>. <source/>Pharmacol, <volume>100</volume>(<issue>5-6</issue>):<fpage>292</fpage>-<lpage>300</lpage>.</mixed-citation>
</ref>
<ref id="b23-ad-11-4-737">
<label>[23]</label>
<mixed-citation publication-type="journal"><name><surname>Tanaka</surname><given-names>KI</given-names></name>, <name><surname>Sugizaki</surname><given-names>T</given-names></name>, <name><surname>Kanda</surname><given-names>Y</given-names></name>, <name><surname>Tamura</surname><given-names>F</given-names></name>, <name><surname>Niino</surname><given-names>T</given-names></name>, <name><surname>Kawahara</surname><given-names>M</given-names></name> (<year>2017</year>). <article-title>Preventive Effects of Carnosine on Lipopolysaccharide-induced Lung Injury</article-title>. <source/>Sci Rep, <volume>7</volume>:<fpage>42813</fpage>.<pub-id pub-id-type="pmid">28205623</pub-id></mixed-citation>
</ref>
<ref id="b24-ad-11-4-737">
<label>[24]</label>
<mixed-citation publication-type="journal"><name><surname>Rothan</surname><given-names>HA</given-names></name>, <name><surname>Abdulrahman</surname><given-names>AY</given-names></name>, <name><surname>Khazali</surname><given-names>AS</given-names></name>, <name><surname>Nor Rashid</surname><given-names>N</given-names></name>, <name><surname>Chong</surname><given-names>TT</given-names></name>, <name><surname>Yusof</surname><given-names>R</given-names></name> (<year>2019</year>). <article-title>Carnosine exhibits significant antiviral activity against Dengue and Zika virus</article-title>. <source/>J Pept Sci, <volume>25</volume>(<issue>8</issue>):<fpage>e3196</fpage>.<pub-id pub-id-type="pmid">31290226</pub-id></mixed-citation>
</ref>
<ref id="b25-ad-11-4-737">
<label>[25]</label>
<mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>T</given-names></name>, <name><surname>Wang</surname><given-names>C</given-names></name>, <name><surname>Zhang</surname><given-names>R</given-names></name>, <name><surname>Xu</surname><given-names>M</given-names></name>, <name><surname>Liu</surname><given-names>B</given-names></name>, <name><surname>Wei</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2015</year>). <article-title>Carnosine markedly ameliorates H9N2 swine influenza virus-induced acute lung injury</article-title>. <source/>J Gen Virol, <volume>96</volume>(<issue>10</issue>):<fpage>2939</fpage>-<lpage>2950</lpage>.<pub-id pub-id-type="pmid">26233716</pub-id></mixed-citation>
</ref>
<ref id="b26-ad-11-4-737">
<label>[26]</label>
<mixed-citation publication-type="journal"><name><surname>Gallego</surname><given-names>M</given-names></name>, <name><surname>Aristoy</surname><given-names>MC</given-names></name>, <name><surname>Toldrá</surname><given-names>F</given-names></name> (<year>2014</year>). <article-title>Dipeptidyl peptidase IV inhibitory peptides generated in Spanish dry-cured ham</article-title>. <source/>Meat Sci, <volume>96</volume>(<issue>2 Pt A</issue>):<fpage>757</fpage>-<lpage>61</lpage><pub-id pub-id-type="pmid">24200567</pub-id></mixed-citation>
</ref>
<ref id="b27-ad-11-4-737">
<label>[27]</label>
<mixed-citation publication-type="journal"><name><surname>Vahdatpour</surname><given-names>T</given-names></name>, <name><surname>Nokhodchi</surname><given-names>A</given-names></name>, <name><surname>Zakeri-Milani</surname><given-names>P</given-names></name>, <name><surname>Mesgari-Abbasi</surname><given-names>M</given-names></name>, <name><surname>Ahmadi-Asl</surname><given-names>N</given-names></name>, <name><surname>Valizadeh</surname><given-names>H</given-names></name> (<year>2019</year>). <article-title>Leucine-glycine and carnosine dipeptides prevent diabetes induced by multiple low-doses of streptozotocin in an experimental model of adult mice</article-title>. <source/>J Diabetes Investig, <volume>10</volume>(<issue>5</issue>):<fpage>1177</fpage>-<lpage>1188</lpage>.</mixed-citation>
</ref>
<ref id="b28-ad-11-4-737">
<label>[28]</label>
<mixed-citation publication-type="journal"><name><surname>Hou</surname><given-names>WC</given-names></name>, <name><surname>Chen</surname><given-names>HJ</given-names></name>, <name><surname>Lin</surname><given-names>YH</given-names></name> (<year>2003</year>). <article-title>Antioxidant peptides with Angiotensin converting enzyme inhibitory activities and applications for Angiotensin converting enzyme purification</article-title>. <source/>J Agric Food Chem, <volume>51</volume>(<issue>6</issue>):<fpage>1706</fpage>-<lpage>9</lpage>.<pub-id pub-id-type="pmid">12617609</pub-id></mixed-citation>
</ref>
<ref id="b29-ad-11-4-737">
<label>[29]</label>
<mixed-citation publication-type="journal"><name><surname>Kilis-Pstrusinska</surname><given-names>K</given-names></name> (<year>2020</year>). <article-title>Carnosine and Kidney Diseases: What We Currently Know?</article-title>
<source/>Curr Med Chem, <volume>27</volume>(<issue>11</issue>):<fpage>1764</fpage>-<lpage>1781</lpage>.<pub-id pub-id-type="pmid">31362685</pub-id></mixed-citation>
</ref>
<ref id="b30-ad-11-4-737">
<label>[30]</label>
<mixed-citation publication-type="journal"><name><surname>Bassendine</surname><given-names>MF</given-names></name>, <name><surname>Bridge</surname><given-names>SH</given-names></name>, <name><surname>McCaughan</surname><given-names>GW</given-names></name>, <name><surname>Gorrell</surname><given-names>MD</given-names></name> (<year>2020</year>). <article-title>Covid-19 and co-morbidities: a role for Dipeptidyl Peptidase 4 (DPP4) in disease severity?</article-title>
<source/>J Diabetes, in press.</mixed-citation>
</ref>
<ref id="b31-ad-11-4-737">
<label>[31]</label>
<mixed-citation publication-type="journal"><name><surname>Magrone</surname><given-names>T</given-names></name>, <name><surname>Magrone</surname><given-names>M</given-names></name>, <name><surname>Jirillo</surname><given-names>E</given-names></name> (<year>2020</year>). <article-title>Focus on Receptors for Coronaviruses with Special Reference to Angiotensin-converting Enzyme 2 as a Potential Drug Target - A Perspective</article-title>. <source/>Endocr Metab Immune Disord Drug Targets, in press.</mixed-citation>
</ref>
<ref id="b32-ad-11-4-737">
<label>[32]</label>
<mixed-citation publication-type="journal"><name><surname>Hewlings</surname><given-names>S</given-names></name>, <name><surname>Kalman</surname><given-names>D</given-names></name> (<year>2020</year>). <article-title>A Review of Zinc-L-Carnosine and Its Positive Effects on Oral Mucositis, Taste Disorders, and Gastrointestinal Disorders</article-title>. <source/>Nutrients, <volume>12</volume>(<issue>3</issue>):<fpage>665</fpage>.</mixed-citation>
</ref>
<ref id="b33-ad-11-4-737">
<label>[33]</label>
<mixed-citation publication-type="journal"><name><surname>Skalny</surname><given-names>AV</given-names></name>, <name><surname>Rink</surname><given-names>L</given-names></name>, <name><surname>Ajsuvakova</surname><given-names>OP</given-names></name>, <name><surname>Aschner</surname><given-names>M</given-names></name>, <name><surname>Gritsenko</surname><given-names>VA</given-names></name>, <name><surname>Alekseenko</surname><given-names>SI</given-names></name>, <etal>et al</etal> (<year>2020</year>). <article-title>Zinc and respiratory tract infections: Perspectives for COVID-19 (Review)</article-title>. <source/>Int J Mol Med, in press.</mixed-citation>
</ref>
<ref id="b34-ad-11-4-737">
<label>[34]</label>
<mixed-citation publication-type="journal"><name><surname>Mucha</surname><given-names>SR</given-names></name>, <name><surname>Dugar</surname><given-names>S</given-names></name>, <name><surname>McCrae</surname><given-names>K</given-names></name>, <name><surname>Joseph</surname><given-names>DE</given-names></name>, <name><surname>Bartholomew</surname><given-names>J</given-names></name>, <name><surname>Sacha</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2020</year>). <article-title>Coagulopathy in COVID-19</article-title>. <source/>Cleve Clin J Med, in press.</mixed-citation>
</ref>
<ref id="b35-ad-11-4-737">
<label>[35]</label>
<mixed-citation publication-type="journal"><name><surname>Hipkiss</surname><given-names>AR</given-names></name> (<year>2019</year>). <article-title>Aging, Alzheimer's Disease and Dysfunctional Glycolysis; Similar Effects of Too Much and Too Little</article-title>. <source/>Aging Dis, <volume>10</volume>(<issue>6</issue>):<fpage>1328</fpage>-<lpage>1331</lpage>.<pub-id pub-id-type="pmid">31788344</pub-id></mixed-citation>
</ref>
<ref id="b36-ad-11-4-737">
<label>[36]</label>
<mixed-citation publication-type="journal"><name><surname>Jacobson</surname><given-names>R</given-names></name>, <name><surname>Mignemi</surname><given-names>N</given-names></name>, <name><surname>Rose</surname><given-names>K</given-names></name>, <name><surname>O'Rear</surname><given-names>L</given-names></name>, <name><surname>Sarilla</surname><given-names>S</given-names></name>, <name><surname>Hamm</surname><given-names>HE</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>The hyperglycemic byproduct methylglyoxal impairs anticoagulant activity through covalent adduction of antithrombin III</article-title>. <source/>Thromb Res, <volume>134</volume>(<issue>6</issue>):<fpage>1350</fpage>-<lpage>7</lpage>.<pub-id pub-id-type="pmid">25307422</pub-id></mixed-citation>
</ref>
<ref id="b37-ad-11-4-737">
<label>[37]</label>
<mixed-citation publication-type="journal"><name><surname>Gugliucci</surname><given-names>A</given-names></name> (<year>2003</year>). <article-title>A practical method to study functional impairment of proteins by glycation and effects of inhibitors using current coagulation/ fibrinolysis reagent kits</article-title>. <source/>Clin Biochem, <volume>36</volume>; <fpage>155</fpage>-<lpage>158</lpage>.<pub-id pub-id-type="pmid">12633766</pub-id></mixed-citation>
</ref>
<ref id="b38-ad-11-4-737">
<label>[38]</label>
<mixed-citation publication-type="journal"><name><surname>Chaleckis</surname><given-names>R</given-names></name>, <name><surname>Murakami</surname><given-names>I</given-names></name>, <name><surname>Takada</surname><given-names>J</given-names></name>, <name><surname>Kondoh</surname><given-names>H</given-names></name>, <name><surname>Yanagida</surname><given-names>M</given-names></name> (<year>2016</year>). <article-title>Individual variability in human blood metabolites identifies age-related differences</article-title>. <source/>Proc Natl Acad Sci U S A, <volume>113</volume>(<issue>16</issue>):<fpage>4252</fpage>-<lpage>9</lpage>.<pub-id pub-id-type="pmid">27036001</pub-id></mixed-citation>
</ref>
<ref id="b39-ad-11-4-737">
<label>[39]</label>
<mixed-citation publication-type="journal"><name><surname>Kameda</surname><given-names>M</given-names></name>, <name><surname>Teruya</surname><given-names>T</given-names></name>, <name><surname>Yanagida</surname><given-names>M</given-names></name>, <name><surname>Kondoh</surname><given-names>H</given-names></name> (<year>2020</year>). <article-title>Frailty markers comprise blood metabolites involved in antioxidation, cognition, and mobility</article-title>. <source/>Proc Natl Acad Sci U S A, in press.</mixed-citation>
</ref>
<ref id="b40-ad-11-4-737">
<label>[40]</label>
<mixed-citation publication-type="journal"><name><surname>Chao de la Barca</surname><given-names>JM</given-names></name>, <name><surname>Rondet-Courbis</surname><given-names>B</given-names></name>, <name><surname>Ferré</surname><given-names>M</given-names></name>, <name><surname>Muller</surname><given-names>J</given-names></name>, <name><surname>Buisset</surname><given-names>A</given-names></name>, <name><surname>Leruez</surname><given-names>S</given-names></name>, <name><surname>Plubeau</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2020</year>). <article-title>A Plasma Metabolomic Profiling of Exudative Age-Related Macular Degeneration Showing Carnosine and Mitochondrial Deficiencies</article-title>. <source/>J Clin Med, <volume>9</volume>(<issue>3</issue>):<fpage>631</fpage></mixed-citation>
</ref>
<ref id="b41-ad-11-4-737">
<label>[41]</label>
<mixed-citation publication-type="journal"><name><surname>Marinova</surname><given-names>Z</given-names></name>, <name><surname>Maercker</surname><given-names>A</given-names></name>, <name><surname>Grünblatt</surname><given-names>E</given-names></name>, <name><surname>Wojdacz</surname><given-names>TK</given-names></name>, <name><surname>Walitza</surname><given-names>S</given-names></name> (<year>2017</year>). <article-title>A pilot investigation on DNA methylation modifications associated with complex posttraumatic symptoms in elderly traumatized in childhood</article-title>. <source/>BMC Res Notes, <volume>10</volume>(<issue>1</issue>):<fpage>752</fpage>.<pub-id pub-id-type="pmid">29258561</pub-id></mixed-citation>
</ref>
<ref id="b42-ad-11-4-737">
<label>[42]</label>
<mixed-citation publication-type="journal"><name><surname>McLaughlin</surname><given-names>KA</given-names></name>, <name><surname>Colich</surname><given-names>NL</given-names></name>, <name><surname>Rodman</surname><given-names>AM</given-names></name>, <name><surname>Weissman</surname><given-names>DG</given-names></name> (<year>2020</year>). <article-title>Mechanisms linking childhood trauma exposure and psychopathology: a transdiagnostic model of risk and resilience</article-title>. <source/>BMC Med, <volume>18</volume>(<issue>1</issue>):<fpage>96</fpage>.<pub-id pub-id-type="pmid">32238167</pub-id></mixed-citation>
</ref>
<ref id="b43-ad-11-4-737">
<label>[43]</label>
<mixed-citation publication-type="journal"><name><surname>Sallis</surname><given-names>HM</given-names></name>, <name><surname>Croft</surname><given-names>J</given-names></name>, <name><surname>Havdahl</surname><given-names>A</given-names></name>, <name><surname>Jones</surname><given-names>HJ</given-names></name>, <name><surname>Dunn</surname><given-names>EC</given-names></name>, <name><surname>Davey Smith</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2020</year>). <article-title>Genetic liability to schizophrenia is associated with exposure to traumatic events in childhood</article-title>. <source/>Psychol Med, <volume>1</volume>:<fpage>1</fpage>-<lpage>8</lpage>.</mixed-citation>
</ref>
<ref id="b44-ad-11-4-737">
<label>[44]</label>
<mixed-citation publication-type="journal"><name><surname>Ishida</surname><given-names>YI</given-names></name>, <name><surname>Kayama</surname><given-names>T</given-names></name>, <name><surname>Kibune</surname><given-names>Y</given-names></name>, <name><surname>Nishimoto</surname><given-names>S</given-names></name>, <name><surname>Koike</surname><given-names>S</given-names></name>, <name><surname>Suzuki</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2017</year>). <article-title>Identification of an argpyrimidine-modified protein in human red blood cells from schizophrenic patients: A possible biomarker for diseases involving carbonyl stress</article-title>. <source/>Biochem Biophys Res Commun, <volume>493</volume>(<issue>1</issue>):<fpage>573</fpage>-<lpage>577</lpage>.<pub-id pub-id-type="pmid">28867194</pub-id></mixed-citation>
</ref>
<ref id="b45-ad-11-4-737">
<label>[45]</label>
<mixed-citation publication-type="journal"><name><surname>Chengappa</surname><given-names>KN</given-names></name>, <name><surname>Turkin</surname><given-names>SR</given-names></name>, <name><surname>DeSanti</surname><given-names>S</given-names></name>, <name><surname>Bowie</surname><given-names>CR</given-names></name>, <name><surname>Brar</surname><given-names>JS</given-names></name>, <name><surname>Schlicht</surname><given-names>PJ</given-names></name>, <etal>et al</etal> (<year>2012</year>). <article-title>A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improve cognition in schizophrenia</article-title>. <source/>Schizophr Res, <volume>142</volume>(<issue>1-3</issue>):<fpage>145</fpage>-<lpage>52</lpage>.<pub-id pub-id-type="pmid">23099060</pub-id></mixed-citation>
</ref>
<ref id="b46-ad-11-4-737">
<label>[46]</label>
<mixed-citation publication-type="journal"><name><surname>Bordoni</surname><given-names>V</given-names></name>, <name><surname>Sacchi</surname><given-names>A</given-names></name>, <name><surname>Cimini</surname><given-names>E</given-names></name>, <name><surname>Notari</surname><given-names>S</given-names></name>, <name><surname>Grassi</surname><given-names>G</given-names></name>, <name><surname>Tartaglia</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2020</year>). <article-title>An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19</article-title>. <source/>Clin Infect Dis, in press.</mixed-citation>
</ref>
<ref id="b47-ad-11-4-737">
<label>[47]</label>
<mixed-citation publication-type="journal"><name><surname>Izquierdo-Dominguez</surname><given-names>A</given-names></name>, <name><surname>Rojas-Lechuga</surname><given-names>MJ</given-names></name>, <name><surname>Mullol</surname><given-names>J</given-names></name>, <name><surname>Alobid</surname><given-names>I</given-names></name> (<year>2020</year>). <article-title>Olfactory dysfunction in the COVID-19 outbreak</article-title>. <source/>J Investig Allergol Clin Immunol, in press.</mixed-citation>
</ref>
<ref id="b48-ad-11-4-737">
<label>[48]</label>
<mixed-citation publication-type="journal"><name><surname>Bonfanti</surname><given-names>L</given-names></name>, <name><surname>Peretto</surname><given-names>P</given-names></name>, <name><surname>De Marchis</surname><given-names>S</given-names></name>, <name><surname>Fasolo</surname><given-names>A</given-names></name> (<year>1999</year>). <article-title>Carnosine-related dipeptides in the mammalian brain</article-title>. <source/>Prog Neurobiol, <volume>59</volume>(<issue>4</issue>):<fpage>333</fpage>-<lpage>53</lpage>.<pub-id pub-id-type="pmid">10501633</pub-id></mixed-citation>
</ref>
<ref id="b49-ad-11-4-737">
<label>[49]</label>
<mixed-citation publication-type="journal"><name><surname>Baraniuk</surname><given-names>JN</given-names></name>, <name><surname>El-Amin</surname><given-names>S</given-names></name>, <name><surname>Corey</surname><given-names>R</given-names></name>, <name><surname>Rayhan</surname><given-names>R</given-names></name>, <name><surname>Timbol</surname><given-names>C</given-names></name> (<year>2013</year>). <article-title>Carnosine treatment for gulf war illness: a randomized controlled trial. Version 2</article-title>. <source/>Glob J Health Sci, <volume>4;5</volume>(<issue>3</issue>):<fpage>69</fpage>-<lpage>81</lpage>.</mixed-citation>
</ref>
<ref id="b50-ad-11-4-737">
<label>[50]</label>
<mixed-citation publication-type="journal"><name><surname>Menon</surname><given-names>K</given-names></name>, <name><surname>Marquina</surname><given-names>C</given-names></name>, <name><surname>Liew</surname><given-names>D</given-names></name>, <name><surname>Mousa</surname><given-names>A</given-names></name>, <name><surname>de Courten</surname><given-names>B</given-names></name> (<year>2020</year>). <article-title>Histidine-containing dipeptides reduce central obesity and improve glycaemic outcomes: A systematic review and meta-analysis of randomized controlled trials</article-title>. <source/>Obes Rev, <volume>21</volume>(<issue>3</issue>):<fpage>e12975</fpage>.<pub-id pub-id-type="pmid">31828942</pub-id></mixed-citation>
</ref>
<ref id="b51-ad-11-4-737">
<label>[51]</label>
<mixed-citation publication-type="journal"><name><surname>Menini</surname><given-names>S</given-names></name>, <name><surname>Iacobini</surname><given-names>C</given-names></name>, <name><surname>Fantauzzi</surname><given-names>CB</given-names></name>, <name><surname>Pugliese</surname><given-names>G</given-names></name> (<year>2020</year>). <article-title>L-carnosine and its Derivatives as New Therapeutic Agents for the Prevention and Treatment of Vascular Complications of Diabetes</article-title>. <source/>Curr Med Chem, <volume>27</volume>(<issue>11</issue>):<fpage>1744</fpage>-<lpage>1763</lpage>.<pub-id pub-id-type="pmid">31296153</pub-id></mixed-citation>
</ref>
<ref id="b52-ad-11-4-737">
<label>[52]</label>
<mixed-citation publication-type="journal"><name><surname>Masuoka</surname><given-names>N</given-names></name>, <name><surname>Yoshimine</surname><given-names>C</given-names></name>, <name><surname>Hori</surname><given-names>M</given-names></name>, <name><surname>Tanaka</surname><given-names>M</given-names></name>, <name><surname>Asada</surname><given-names>T</given-names></name>, <name><surname>Abe</surname><given-names>K</given-names></name>
<etal>et al</etal> (<year>2019</year>). <article-title>Effects of Anserine/Carnosine Supplementation on Mild Cognitive Impairment with APOE4</article-title>. <source/>Nutrients, <volume>11</volume>(<issue>7</issue>):<fpage>1626</fpage>.</mixed-citation>
</ref>
<ref id="b53-ad-11-4-737">
<label>[53]</label>
<mixed-citation publication-type="journal"><name><surname>Chez</surname><given-names>MG</given-names></name>, <name><surname>Buchanan</surname><given-names>CP</given-names></name>, <name><surname>Aimonovitch</surname><given-names>MC</given-names></name>, <name><surname>Becker</surname><given-names>M</given-names></name>, <name><surname>Schaefer</surname><given-names>K</given-names></name>, <name><surname>Black</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2002</year>). <article-title>Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders</article-title>. <source/>J Child Neurol, <volume>17</volume>(<issue>11</issue>):<fpage>833</fpage>-<lpage>7</lpage>.<pub-id pub-id-type="pmid">12585724</pub-id></mixed-citation>
</ref>
<ref id="b54-ad-11-4-737">
<label>[54]</label>
<mixed-citation publication-type="journal"><name><surname>Hajizadeh-Zaker</surname><given-names>R</given-names></name>, <name><surname>Ghajar</surname><given-names>A</given-names></name>, <name><surname>Mesgarpour</surname><given-names>B</given-names></name>, <name><surname>Afarideh</surname><given-names>M</given-names></name>, <name><surname>Mohammadi</surname><given-names>MR</given-names></name>, <name><surname>Akhondzadeh</surname><given-names>S</given-names></name> (<year>2018</year>). <article-title>L-Carnosine as an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial</article-title>. <source/>J Child Adolesc Psychopharmacol, <volume>28</volume>(<issue>1</issue>):<fpage>74</fpage>-<lpage>81</lpage>.<pub-id pub-id-type="pmid">29027815</pub-id></mixed-citation>
</ref>
<ref id="b55-ad-11-4-737">
<label>[55]</label>
<mixed-citation publication-type="journal"><name><surname>Lombardi</surname><given-names>C</given-names></name>, <name><surname>Carubelli</surname><given-names>V</given-names></name>, <name><surname>Lazzarini</surname><given-names>V</given-names></name>, <name><surname>Vizzardi</surname><given-names>E</given-names></name>, <name><surname>Bordonali</surname><given-names>T</given-names></name>, <name><surname>Ciccarese</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2015</year>). <article-title>Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure</article-title>. <source/>Nutrition, <volume>31</volume>(<issue>1</issue>):<fpage>72</fpage>-<lpage>8</lpage>.<pub-id pub-id-type="pmid">25287762</pub-id></mixed-citation>
</ref>
<ref id="b56-ad-11-4-737">
<label>[56]</label>
<mixed-citation publication-type="journal"><name><surname>Rodriguez-Niño</surname><given-names>A</given-names></name>, <name><surname>Hauske</surname><given-names>SJ</given-names></name>, <name><surname>Herold</surname><given-names>A</given-names></name>, <name><surname>Qiu</surname><given-names>J</given-names></name>, <name><surname>van den Born</surname><given-names>J</given-names></name>, <name><surname>Bakker</surname><given-names>SJL</given-names></name>, <etal>et al</etal> (<year>2019</year>). <article-title>Serum Carnosinase-1 and Albuminuria Rather than the CNDP1 Genotype Correlate with Urinary Carnosinase-1 in Diabetic and Nondiabetic Patients with Chronic Kidney Disease</article-title>. <source/>J Diabetes Res, in press.</mixed-citation>
</ref>
<ref id="b57-ad-11-4-737">
<label>[57]</label>
<mixed-citation publication-type="journal"><name><surname>Bauer</surname><given-names>K</given-names></name> (<year>2005</year>). <article-title>Carnosine and homocarnosine, the forgotten, enigmatic peptides of the brain</article-title>. <source/>Neurochem Res, <volume>30</volume>(<issue>10</issue>):<fpage>1339</fpage>-<lpage>45</lpage>.<pub-id pub-id-type="pmid">16341596</pub-id></mixed-citation>
</ref>
<ref id="b58-ad-11-4-737">
<label>[58]</label>
<mixed-citation publication-type="journal"><name><surname>Chmielewska</surname><given-names>K</given-names></name>, <name><surname>Dzierzbicka</surname><given-names>K</given-names></name>, <name><surname>Inkielewicz-Stępniak</surname><given-names>I</given-names></name>, <name><surname>Przybyłowska</surname><given-names>M</given-names></name> (<year>2020</year>). <article-title>Therapeutic Potential of Carnosine and Its Derivatives in the Treatment of Human Diseases</article-title>. <source/>Chem Res Toxicol, in press.</mixed-citation>
</ref>
<ref id="b59-ad-11-4-737">
<label>[59]</label>
<mixed-citation publication-type="journal"><name><surname>Hipkiss</surname><given-names>AR</given-names></name>, <name><surname>Baye</surname><given-names>E</given-names></name>, <name><surname>de Courten</surname><given-names>B</given-names></name> (<year>2016</year>). <article-title>Carnosine and the processes of ageing</article-title>. <source/>Maturitas, <volume>93</volume>:<fpage>28</fpage>-<lpage>33</lpage>.<pub-id pub-id-type="pmid">27344459</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>